0001950047-23-000035.txt : 20230316 0001950047-23-000035.hdr.sgml : 20230316 20230316165128 ACCESSION NUMBER: 0001950047-23-000035 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230316 DATE AS OF CHANGE: 20230316 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-41199 FILM NUMBER: 23739530 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-683-0917 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MILNE GEORGE M JR CENTRAL INDEX KEY: 0001179552 FILING VALUES: FORM TYPE: 144 144 1 primary_doc.xml 144 0001179552 XXXXXXXX LIVE 0001658551 AMYLYX PHARMACEUTICALS INC 001-41199 43 THORNDIKE STREET CAMBRIDGE MA 02141 617-683-0917 George Mclean Milne, Jr. Director COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Fl. New York NY 10004

35000 1176000.00 66716388 03/16/2023 NASDAQ Common 08/08/2016 Restricted Stock Units Issuer N 35000 08/08/2016 N/A Y 03/16/2023 11/16/2022 /s/ George Mclean Milne Jr